Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2
The experimentally established mechanism targets of Glutarate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.52 |
| ▸ | BBOX1 | O75936 | 10/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azelaic Acid SCHEMBL8087669 | 0.93 | BBOX1 (0.50) | MEN1LMNAKMT2ACYP3A4SLC5A7 | |
| Sebacic Acid SCHEMBL15378185 | 0.91 | BBOX1 (0.48) | MEN1LMNAKMT2ACYP3A4SLC5A7 | |
| Succinic Acid SCHEMBL3191898 | 0.91 | MEN1 (0.57) | MEN1LMNAKMT2ACYP3A4SLC5A7 | |
| Succinic Acid SCHEMBL6627654 | 0.88 | CYP3A4 (0.62) | MEN1LMNAKMT2ACYP3A4SLC5A7 | |
| Succinic Acid SCHEMBL27491383 | 0.88 | MEN1 (0.62) | MEN1LMNAKMT2ACYP3A4SLC5A7 | |
| Hexanoate SCHEMBL2762274 | 0.88 | CA1 (0.54) | BBOX1CA1 | |
| Myristic Acid SCHEMBL8588822 | 0.86 | FABP3 (0.55) | BBOX1CA1 | |
| Octanoic Acid SCHEMBL2761867 | 0.86 | FABP3 (0.55) | BBOX1CA1 | |
| Dodecanoate SCHEMBL19253062 | 0.86 | FABP3 (0.55) | BBOX1CA1 | |
| Decanoic Acid SCHEMBL580470 | 0.86 | FABP3 (0.55) | BBOX1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023174433-A1 | SOLID, SEMISOLID, OR LIQUID COMPOSITIONS FOR AUGMENTING THE STABILITY, PERMEABILITY AND BIOAVAILABILITY OF ACTIVE PHARMACEUTICAL SUBSTANCES | Smart Pharmaceutical (Suzhou) Co., Ltd. (CN) | 2023-09-21 | — | — | WO | claimed |
| CN-116725011-A | Promotion of germination of mung bean seeds by exogenous choline glutaric acid | 西北农林科技大学 | 2023-09-12 | — | — | CN | claimed |
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-12-25 | — | — | US | disclosed |
| EP-3256850-B1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES INC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-12352679-B2 | Synthetic human cell mimic particle for cytometric or coulter device | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-07-08 | — | — | US | disclosed |
| US-20250164373-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-05-22 | — | — | US | disclosed |
| WO-2025090968-A1 | HYDROGEL CELL MIMICS WITH SUBCELLULAR FEATURES | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-05-01 | — | — | WO | disclosed |
| US-12196661-B2 | Size-tunable synthetic particles with tunable optical properties and methods for using the same for immune cell activation | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240353305-A1 | SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION | SLINGSHOT BIOSCIENCES, INC. | 2024-10-24 | — | — | US | disclosed |
| US-12066369-B2 | Synthetic human cell mimic particle for cytometric or coulter device | SLINGSHOT BIOSCIENCES, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| US-20240159645-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| CN-113939273-A | Ionic liquids for drug delivery | 哈佛大学校长及研究员协会 | 2022-01-14 | — | — | CN | disclosed |
| US-20200400546-A1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES, INC. (US) | 2020-12-24 | — | — | US | disclosed |
| WO-2020205409-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-10-08 | — | — | WO | disclosed |
| US-10753846-B2 | Hydrogel particles with tunable optical properties and methods for using the same | SLINGSHOT BIOSCIENCES, INC. (US) | 2020-08-25 | — | — | US | disclosed |
| US-20180275040-A1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES, INC. (US) | 2018-09-27 | — | — | US | disclosed |
| EP-3256850-A1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | Slingshot Biosciences, Inc. (US) | 2017-12-20 | — | — | EP | disclosed |
| US-9714897-B2 | Hydrogel particles with tunable optical properties and methods for using the same | SLINGSHOT BIOSCIENCES, INC. (US) | 2017-07-25 | — | — | US | disclosed |
| US-20160258856-A1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES, INC. | 2016-09-08 | — | — | US | disclosed |
| WO-2016130489-A1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES, INC. (US) | 2016-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | CD4, ICOS, CD69 | MEN1 3203/4885LMNA 3949/4885KMT2A 2367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.